- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Therapeutic rationale for mTOR inhibition in advanced renal cell carcinoma - Abstract
September 26, 2011
Prognostic model for survival in patients with metastatic renal cell carcinoma: Results from the International Kidney Cancer Working Group - Abstract
September 26, 2011
Toxicities of targeted agents in advanced renal cell carcinoma - Abstract
September 23, 2011
VEGF inhibitors in metastatic renal cell carcinoma: Current therapies and future perspective - Abstract
September 23, 2011
DGU 2011 - Treatment of patients with metastatic renal cell carcinoma: Reality in Germany - Session Highlights
September 23, 2011
DGU 2011 - Histologic subtypes of renal cell carcinoma demonstrate different activation of the mTOR pathway - Session Highlights
September 23, 2011
Emerging targeted therapies in metastatic renal cell carcinoma - Abstract
September 22, 2011
Immunotherapy of kidney cancer - Abstract
September 22, 2011
Immunotherapy and targeted therapy combinations in renal cancer - Abstract
September 22, 2011
DGU 2011 - Nephron-sparing surgery in patients with renal tumors >7 cm: Functional and oncological outcome - Session Highlights
September 22, 2011
Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma - Abstract
September 21, 2011
miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma - Abstract
September 21, 2011
Graft reconstruction of inferior vena cava for renal cell carcinoma stage pT3b or greater - Abstract
September 21, 2011
Retrograde venous invasion in renal cell carcinoma: A complication of sinus vein and main renal vein invasion - Abstract
September 20, 2011
Treatment-related optimism protects quality of life in a phase II clinical trial for metastatic renal cell carcinoma - Abstract
September 20, 2011